B57.39
Other digestive system involvement in Chagas' disease
Clinical Classification Guidelines
Medical Intelligence & Overview
Chagas' disease, also known as American trypanosomiasis, is a parasitic infection caused by the protozoan Trypanosoma cruzi. It is primarily transmitted through insect vectors, but can also spread via contaminated food, blood transfusions, and from mother to child during childbirth. The disease has an acute phase that may be mild or asymptomatic, followed by a chronic phase that can lead to serious complications including effects on the digestive system. The ICD-10 code B57.39 specifically pertains to cases where Chagas' disease involves other parts of the digestive system beyond the heart and esophagus, highlighting its potential impact on gastrointestinal health.
Causes & Symptoms
Clinical Causes: Infection with Trypanosoma cruzi parasite Transmission through triatomine bugs (kissing bugs) Contaminated food or drink containing the parasite Blood transfusions from infected donors Congenital transmission from mother to child
Key Symptoms: Difficulty swallowing or esophageal pain Abdominal discomfort or bloating Constipation or irregular bowel movements Digestive tract inflammation or ulcers Nausea or vomiting Unintended weight loss Malnutrition symptoms due to digestive complications
Diagnostic & Treatment
Diagnosis Path: Diagnosis of digestive involvement in Chagas' disease involves a combination of clinical assessment and laboratory tests. Blood tests can detect signs of parasitic infection or antibodies against Trypanosoma cruzi. Imaging techniques like X-rays, barium studies, or endoscopy may reveal structural changes in the gastrointestinal tract, such as megacolon or esophageal dilation. In some cases, biopsy samples taken from affected tissues can identify parasitic agents or tissue damage associated with the infection.
Treatment Protocols: Treatment options focus on eliminating the parasite and managing gastrointestinal symptoms. Antiparasitic medications, such as benznidazole or nifurtimox, are commonly used to treat the infection, especially in the early stages. Supportive therapies may include dietary modifications, medications to improve motility, or surgical interventions in severe cases of gastrointestinal dilatation. Regular follow-up is crucial to monitor disease progression and address complications promptly.
Clinical Advice & FAQs
Billing Guidance
Is B57.39 a billable ICD-10 code?
Yes, B57.39 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report B57.39?
Clinical documentation must specify the nature of Other digestive system involvement in Chagas' disease and any associated comorbidities for accurate reporting.
Cite this Clinical Reference